Evidence map›Paper›PMID 25891073›Full record

ArticleMolecular cell2015

ATP-dependent effector-like functions of RIG-I-like receptors.

Hui Yao, Meike Dittmann, Alys Peisley, Hans-Heinrich Hoffmann, Rachel H Gilmore, Tobias Schmidt, Jonathan Schmidt-Burgk, Veit Hornung, Charles M Rice, Sun Hur

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Differential roles of RIG-I-like receptors in SARS-CoV-2 infection.bioRxiv : the preprint server for biology · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. LncRNAs in the Type I Interferon Antiviral Response.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Hui Yao *Program in Cellular and Molecular Medicine, Children's Hospital Boston, MA 02115, USA.
Meike Dittmann *Laboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C The Rockefeller University, New York, New York 10065, USA.
Alys PeisleyProgram in Cellular and Molecular Medicine, Children's Hospital Boston, MA 02115, USA.
Hans-Heinrich HoffmannLaboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C The Rockefeller University, New York, New York 10065, USA.
Rachel H GilmoreLaboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C The Rockefeller University, New York, New York 10065, USA.
Tobias SchmidtInstitut für Molekulare Medizin, Universitätsklinikum Bonn, 53127 Bonn, Germany.
Jonathan Schmidt-BurgkInstitut für Molekulare Medizin, Universitätsklinikum Bonn, 53127 Bonn, Germany.
Veit HornungInstitut für Molekulare Medizin, Universitätsklinikum Bonn, 53127 Bonn, Germany.
Charles M RiceLaboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C The Rockefeller University, New York, New York 10065, USA.
Sun HurProgram in Cellular and Molecular Medicine, Children's Hospital Boston, MA 02115, USA.
Rockefeller University · USBoston Children's Hospital · USUniversity Hospital Bonn · DE

Funding

Type I interferon-stimulated genes and the antiviral immune responseR01AI091707 · NIAID · ROCKEFELLER UNIVERSITY · PI RICE, CHARLES M · 2011 to 2020
$5.5M
Structural and functional analyses of the RIG-I filament in innate immunityR01AI111784 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI HUR, SUN · 2014 to 2023
$4.9M
Molecular Mechanisms for Antiviral Signal Activation by MDA5 and RIG-IR01AI106912 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI HUR, SUN · 2014 to 2018
$2.2M
NIAID NIH HHS R01 AI091707NIAID NIH HHS R01 AI106912NIAID NIH HHS R01 AI111784
6 · The paper itself

Abstract

The vertebrate antiviral innate immune system is often considered to consist of two distinct groups of proteins: pattern recognition receptors (PRRs) that detect viral infection and induce the interferon (IFN) signaling, and effectors that directly act against viral replication. Accordingly, previous studies on PRRs, such as RIG-I and MDA5, have primarily focused on their functions in viral double-stranded RNA (dsRNA) detection and consequent antiviral signaling. We report here that both RIG-I and MDA5 efficiently displace viral proteins pre-bound to dsRNA in a manner dependent on their ATP hydrolysis, and that this activity assists a dsRNA-dependent antiviral effector protein, PKR, and allows RIG-I to promote MDA5 signaling. Furthermore, truncated RIG-I/MDA5 lacking the signaling domain, and hence the IFN stimulatory activity, displaces viral proteins and suppresses replication of certain viruses in an ATP-dependent manner. Thus, this study reveals novel "effector-like" functions of RIG-I and MDA5 that challenge the conventional view of PRRs.

Indexed as

Adenosine TriphosphateAntiviral AgentsBase SequenceBlotting, WesternCell Line, TumorDEAD Box Protein 58DEAD-box RNA HelicaseseIF-2 KinaseHEK293 CellsHumansInterferon-betaInterferon-Induced Helicase, IFIH1Models, MolecularMutationNucleic Acid ConformationPhosphorylationAdenosine TriphosphateAntiviral AgentsDEAD Box Protein 58DEAD-box RNA HelicaseseIF-2 KinaseIFIH1 protein, humanInterferon-betaInterferon-Induced Helicase, IFIH1Receptors, ImmunologicReceptors, Pattern RecognitionRIGI protein, humanRNA, Double-StrandedRNA, ViralViral Proteins

Identifiers

PMID25891073
PMCPMC4427555
OpenAlexW1965250565

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.